Augpac: Use in pregnancy: Safety in pregnancy has not been established.
Amoxicillin and clavulanate potassium is in the FDA pregnancy category B.
This means that it is not expected to be harmful to an unborn infant. Do not, however, take Augpac without first talking to the physician if the patient is pregnant or could become pregnant during treatment.
Augpac Injection: Use in pregnancy should be avoided. Amoxicillin sodium and clavulanate potassium for injection may be given during lactation. With the exception of the risk of sensitization, associated with the excretion of trace amount in breast milk, there are no detrimental effects for the infant.